safety
and
antigenicity
of
inactivated
influenza
virus
vaccines
in
children
trials
with
monovalent
and
bivalent
a
new
jersey
hswn
and
a
victoria
virus
vaccines
in
washington
d
c
safety
and
antigenicity
of
monovalent
and
bivalent
a
new
jersey
nj
hssn
and
a
victoria
inactivated
influenza
virus
vaccines
were
studied
in
children
aged
three
to
years
in
recruitment
families
who
knew
the
study
team
who
were
professionally
involved
and
or
who
were
under
close
continuing
care
were
more
likely
to
volunteer
for
such
studies
than
those
who
were
unfamiliar
with
the
team
or
institution
antibody
responses
and
systemic
reactions
occurred
more
often
after
administration
of
inactivated
whole
virus
vaccine
than
after
split
virus
vaccine
significant
titers
greater
than
or
equal
to
of
hemagglutination
inhibiting
antibody
to
a
nj
virus
occurred
in
of
normal
children
three
to
years
of
age
who
received
two
doses
of
the
same
vaccine
whole
or
split
however
insufficient
numbers
of
children
achieved
a
reasonable
antibody
titer
greater
than
or
equal
to
after
one
dose
of
vaccine
